Insider Trading History of Donelan Patrick

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Donelan Patrick since 2009. The trader's CIK number is 1357631. At the time of the last reporting, Donelan Patrick was the 10% Owner of United Health Products, Inc.. (stock ticker symbol UEEC). Also see all insider trading activities at United Health Products, Inc..

Note that in the past Donelan Patrick also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at American Development & Investment Fund, Inc. (ADIF) by Donelan Patrick

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2009 ADIF 0 $0 5,423,234 $5,423 0 $0

Yearly summary of insider trading at United Health Products, Inc. (UEEC) by Donelan Patrick

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 UEEC 0 $0 1,204,603 $1,204 0 $0
2009 UEEC 0 $0 675,000 $675 0 $0


Insider trading activities at 2 companies by Donelan Patrick:

1. American Development & Investment Fund, Inc. (ADIF)

2. United Health Products, Inc. (UEEC)

Table 1. Insider trading of American Development & Investment Fund, Inc. (ADIF) by Donelan Patrick

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2009-06-12 ADIF Sale 5,423,234 .00 5,423

Table 2. Insider trading of United Health Products, Inc. (UEEC) by Donelan Patrick

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-01-25 UEEC Sale 1,204,603 .00 1,204
2009-07-22 UEEC Sale 500,000 .00 500
2009-06-01 UEEC Sale 40,000 .00 40
2009-05-18 UEEC Sale 135,000 .00 135

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Donelan Patrick (10% Owner of United Health Products, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.